positiveSYS.SOURCE: TechCrunch• 2026-09-23T19:31:28Z
Enveda Raises $311 Million for AI-Driven Natural Compound Drug Development
Enveda, a biotech startup leveraging AI to discover drugs from natural sources, secured $311 million in Series E funding at a $2 billion valuation. The company is advancing AI-discovered candidates into clinical trials, including treatments for skin conditions and weight loss management.
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
*** END OF TRANSMISSION ***